Member Info for Timster

doing well here thats 4 cross ramps :)

ODX don't use Affimers by the way

same happened for the original DR fella who started tweeting regularly. It's obviously still a secret!

Ah ****** 0.98 down today !!! I wish we were ncyt

probably finish level

because of reporting no doubt, its the way forward

while we wait
https://avacta.com/wp-content/uploads/2020/09/Avacta-Group-plc-Interim-Results-September-2020-v2.pdf

Where were the doom merchants on the strong blue days we had? Then when you have the answer filter them, there's is zero value in what they post

yep time to filter for me too, obviously a complete and utter twat

WHAT PL75 I just told the daily mail reporter big Al promised £200 ex China!!!
I can't believe it

Down .8%, still no test, rudderless ship while bug Al hogs the tea earn. OH I wish I was in ncyt sob sobel sob ....

great find

@Indy 177, that's really scary

p.s its 180 now do we need a running commentary

never going to be a straight line gain, we will have days whilst waiting for news when it might drop slightly.

But who cares! the news we are waiting for wont give us a 1 or 2% rise more like 100%

this is what will land in Q4:
1. Data from phase I clinical trial of AVA6000 Pro-doxorubicin
Aiming for UK regulatory filing (CTA) 4Q20

2. SARS-CoV-2 rapid antigen test
• Aiming for clinical validation 4Q20
• Initial CE self-certification for professional use
• CE marking for consumer self-testing running in parallel
• Additional commercial opportunities for SARS-CoV-2 spike protein Affimers

3. Licensing and commercial partnerships both Dx and Tx
• Core Dx business licensing opportunities
• Partnering of therapeutic assets and/or new collaborative development partnerships

I'm not worried....

https://avacta.com/wp-content/uploads/2020/09/Avacta-Group-plc-Interim-Results-September-2020-v2.pdf
slide 29

Avacta is expanding its in-house Affimer production facilities and putting in place very
large scale contract manufacturing partners; Affimer supply will not be a limiting factor
and nor will nitrocellulose strip.
• Avacta has partnered with BBI Solutions and Abingdon Health to date, who can
manufacture several millions of lateral flow test strips per month.
• UK strip manufacturing capacity needs to be scaled rapidly to address the anticipated
volume requirements and additional capacity is being put in place overseas.
• Kit assembly is a challenge and partners in the UK have been identified and additional
resources overseas are being put in place.
• Detailed discussions with regulatory authorities, governments and healthcare providers
are ongoing but are strictly confidential.

great posts Seagull

Good effort there anuj very sneaky ...

Great reply Richken, we have news on multiple fronts due in Q4 not just a one trip covid pony

Affimers detect covid Including the D614G mutant of SARS-CoV-2 S1
Slide 20
https://avacta.com/wp-content/uploads/2020/09/Avacta-Group-plc-Interim-Results-September-2020-v2.pdf

Agreed, it's not the cross ramping though it's the taunting like someone said we aren't football teams try to out do each other it's boring.
Be happy with your investment in one or many stocks. I personally don't give two flucks about ODX or ncyt I've put all my eggs in the Avacta basket. But good luck to everyone with thier choices of investment.

@trek think you put the wrong link in

..